Species differences in the disposition of acyclovir

作者: Paulo de Miranda , Harvey C. Krasny , Donna A. Page , Gertrude B. Elion

DOI: 10.1016/0002-9343(82)90059-6

关键词:

摘要: The disposition of acyclovir was investigated in several species. drug well distributed into all the tissues, including brain, mice and rats. Binding to plasma proteins 36 percent or lower. After intravenous bolus dosing (20 mg/kg) dogs, concentration-time profile, determined by radioimmunoassay, showed a biphasic decline with half-life elimination phase 2.3 +/- 0.1 hours. volume distribution (Vd beta) 1.2 0.2 liters/kg indicated tissues. Marked species differences were observed gastrointestinal absorption biotransformation acyclovir. Oral produced better dogs than rats rhesus monkeys. More 95 radioactivity urine derived from 14C-acyclovir parenteral dose recovered as unchanged mice, rats, dogs. Minor urinary metabolites characterized high-performance liquid chromatography 9-carboxymethoxymethylguanine (CMMG) 8-hydroxy-9-(2-hydroxyethoxymethyl)guanine. In other species--guinea pig, rabbit, monkey--up 40 consisted these metabolites.

参考文章(8)
James G. Cunningham, Textbook of Veterinary Physiology ,(1971)
H C Krasny, G B Elion, P de Miranda, M R Blum, Pharmacokinetics and bioavailability of acyclovir in the dog. Journal of Pharmacology and Experimental Therapeutics. ,vol. 216, pp. 281- 288 ,(1981)
Steven S. Good, Paulo De Miranda, Metabolic disposition of acyclovir in the guinea pig, rabbit, and monkey The American Journal of Medicine. ,vol. 73, pp. 91- 95 ,(1982) , 10.1016/0002-9343(82)90071-7
R.P. Quinn, P. de Miranda, L. Gerald, S.S. Good, A sensitive radioimmunoassay for the antiviral agent BW248U [9-(2-hydroxyethoxymethyl)guanine]. Analytical Biochemistry. ,vol. 98, pp. 319- 328 ,(1979) , 10.1016/0003-2697(79)90148-9
H. J. Schaeffer, Lilia Beauchamp, P. de Miranda, Gertrude B. Elion, D. J. Bauer, P. Collins, 9-(2-Hydroxyethoxymethyl)guanine activity against viruses of the herpes group Nature. ,vol. 272, pp. 583- 585 ,(1978) , 10.1038/272583A0
Paulo de Miranda, Steven S Good, Oscar L Laskin, Harvey C Krasny, James D Connor, Paul S Lietman, Disposition of intravenous radioactive acyclovir Clinical Pharmacology and Therapeutics. ,vol. 30, pp. 662- 672 ,(1981) , 10.1038/CLPT.1981.218
H C Krasny, G B Elion, D A Page, P de Miranda, The disposition of acyclovir in different species. Journal of Pharmacology and Experimental Therapeutics. ,vol. 219, pp. 309- 315 ,(1981)
P. de Miranda, R. J. Whitley, M. R. Blum, R. E. Keeney, N. Barton, D. M. Cocchetto, S. Good, G. P. Hemstreet, L. E. Kirk, D. A. Page, G. B. Elion, Acyclovir kinetics after intravenous infusion. Clinical Pharmacology & Therapeutics. ,vol. 26, pp. 718- 728 ,(1979) , 10.1002/CPT1979266718